{"id":1063391,"date":"2012-12-09T07:51:01","date_gmt":"2012-12-09T07:51:01","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/extra-extra-cirm-staffers-blog-the-world-stem-cell-summit\/"},"modified":"2024-08-17T20:29:12","modified_gmt":"2024-08-18T00:29:12","slug":"extra-extra-cirm-staffers-blog-the-world-stem-cell-summit-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/extra-extra-cirm-staffers-blog-the-world-stem-cell-summit-2.php","title":{"rendered":"Extra, Extra! CIRM Staffers Blog the World Stem Cell Summit"},"content":{"rendered":"

Years ago, I worked with an editor who
used to advise his lagging scribes to put their noses in their
typewriters and peck.<\/p>

<\/div>
Well, the folks at the California stem cell agency have their
noses in what passes today for typewriters and are pecking away
furiously. Their subject is the World Stem Cell Summit<\/b>, which has
received only slight coverage in the mainstream media.<\/div>
<\/div>
Today, the stem “cellists” from San
Francisco's King Street filed -- on the agency's blog<\/a> -- three fulsome
items on doings at the summit, which is taking place in West Palm
Beach, Fla. Yesterday they filed four. Photos and charts were
included. More coverage is expected tomorrow.<\/div>
<\/div>
<\/a><\/td><\/tr>
CIRM staffers blogging the World Stem Cell Summit
covered UC Davis researcher Paul Knoepfler discussing
patient advocacy and its role in funding stem cell research. <\/td><\/tr><\/tbody><\/table>

The CIRM writers are doing double-duty
in at least one case. Geoff Lomax<\/b>, the agency's senior officer for
its standards group, is additionally speaking on a panel at the session. A
handful of other CIRM officials are also appearing at the conference,
which ends tomorrow.<\/p><\/div>

<\/div>
The primary purpose, we presume, of
sending state employees across the country is to gather the latest
information on stem cell science and issues and to make contacts. It
is a bit of a bonus for the public to have the CIRM attendees also
file stories on the sessions.<\/div>
<\/div>
A couple of the items caught my
attention. One dealt with patient advocates and their role<\/a> in
energizing and helping to drive funding for research. Another item
discussed what appear to be growing issues with dubious stem cell treatments and the damage they can do<\/a> to the field in general.<\/div>
<\/div>
Lomax summarized the signs of a stem
cell scam like this:<\/div>